Format

Send to

Choose Destination
Emerg Infect Dis. 2002 Feb;8(2):181-7.

Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Author information

1
University of British Columbia and Children's and Women's Health Centre of British Columbia, Vancouver, Canada. speert@interchange.ubc.ca

Abstract

The Burkholderia cepacia complex is an important group of pathogens in patients with cystic fibrosis (CF). Although evidence for patient-to-patient spread is clear, microbial factors facilitating transmission are poorly understood. To identify microbial clones with enhanced transmissibility, we evaluated B. cepacia complex isolates from patients with CF from throughout Canada. A total of 905 isolates from the B. cepacia complex were recovered from 447 patients in 8 of the 10 provinces; 369 (83%) of these patients had genomovar III and 43 (9.6%) had B. multivorans (genomovar II). Infection prevalence differed substantially by region (22% of patients in Ontario vs. 5% in Quebec). Results of typing by random amplified polymorphic DNA analysis or pulsed-field gel electrophoresis indicated that strains of B. cepacia complex from genomovar III are the most potentially transmissible and that the B. cepacia epidemic strain marker is a robust marker for transmissibility.

PMID:
11897071
PMCID:
PMC3369581
DOI:
10.3201/eid0802.010163
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center